This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Luo, C. Articles by Yue, D.K. PubMed Articles by Luo, C. Articles by Yue, D.K. Social Bookmarking                         What's this?

Hypovitaminosis D in Chinese type 2 diabetes: Lack of impact on clinical metabolic status and biomarkers of cellular inflammation

The Diabetes Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia, connie.luo{at}email.cs.nsw.gov.au

J. Wong

The Diabetes Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia, Discipline of Medicine, University of Sydney, Sydney, New South Wales, Australia

M. Brown

Discipline of Medicine, University of Sydney, Sydney, New South Wales, Australia

M. Hooper

Discipline of Medicine, University of Sydney, Sydney, New South Wales, Australia

L. Molyneaux

The Diabetes Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia, Discipline of Medicine, University of Sydney, Sydney, New South Wales, Australia

D.K. Yue

The Diabetes Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia, Discipline of Medicine, University of Sydney, Sydney, New South Wales, Australia

Objective: Low vitamin D (25 OH vitamin D) is implicated in the development of diabetes and the metabolic syndrome. We examined whether hypovitaminosis D has a clinically significant impact on glycaemia, metabolic status and inflammatory markers in Chinese patients with established type 2 diabetes.

Methods: Characteristics of 109 patients aged over 50 years were stratified by 25 OH vitamin D status. Patients identified as 25 OH vitamin D deficient ( 50 nmol/L) received cholecalciferol 2,000 IU daily for three months. Measurement of HbA1c, metabolic syndrome parameters, 25 OH vitamin D, calcium, phosphate, PTH, hsCRP and ferritin were taken at baseline and then 25 OH vitamin D, PTH, calcium, phosphate monthly for three months in those on replacement therapy.

Results: Vitamin D deficiency was common, affecting 36% of patients. There was no impact of hypovitaminosis D on metabolic syndrome status, HbA1c or insulin use (p 0.4 for all) and no association between 25OHVitD and ferritin or hsCRP (p 0.3 for all). Neither BMI nor the metabolic syndrome affected the incremental rise in 25OHVitD levels during supplementation.

Conclusion: There is no relationship between hypovitaminosis D and metabolic control or inflammatory markers in established type 2 diabetes.This suggests that at least in Chinese populations, the effect of low vitamin D is not clinically significant once diabetes is established. Future 25OHVitD intervention trials should therefore focus on prevention in pre-diabetes.

Key Words: diabetes • vitamin D • metabolic syndrome • obesity complications

Diabetes and Vascular Disease Research, Vol. 6, No. 3, 194-199 (2009)
DOI: 10.1177/1479164109337974


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?